NCT01745198View on ClinicalTrials.gov

Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease Related Disorders
Trial Locations (1)

92663

Hoag Memorial Hospital, Newport Beach

All Listed Sponsors
collaborator

The Shankle Clinic

UNKNOWN

collaborator

Hoag Memorial Hospital Presbyterian

OTHER

lead

Pamlab, Inc.

INDUSTRY

NCT01745198 - Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements | Biotech Hunter | Biotech Hunter